Fortrea Holdings (FTRE) Net Cash Flow (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Net Cash Flow came in at $21.9 million in Q2 2026, up 188.66% on a YoY basis from $7.6 million in Q2 2025, and up 187.6% quarter-over-quarter from -$25.0 million in Q1 2026.
Analysis
Fortrea Holdings (FTRE) Net Cash Flow (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has reported Net Cash Flow for 5 consecutive years, with $21.9 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Cash Flow rose 188.66% year-over-year to $21.9 million; the trailing twelve-month figure through Jun 2026 stood at $92.9 million (up 288.06% YoY), and the FY2025 full-year result was $51.6 million, up 210.84% from the prior year.
- Net Cash Flow advanced to $21.9 million in Q2 2026 per FTRE's latest filing, from -$25.0 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $50.1 million in Q3 2025 and bottomed at -$25.0 million in Q1 2026.
- Historically, Net Cash Flow has averaged $4.8 million across 5 years, with a median of $450000.0 in 2022.
- The widest YoY moves for Net Cash Flow: up 1047.06% in 2024, down 690.32% in 2024.
- Over 5 years, Net Cash Flow stood at -$800000.0 in 2022, then surged by 312.5% to $1.7 million in 2023, then jumped by 1047.06% to $19.5 million in 2024, then jumped by 135.38% to $45.9 million in 2025, then sank by 52.29% to $21.9 million in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered $21.9 million, -$25.0 million, and $45.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | -37.00 Mn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | -150.21 Mn |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | 43.16 Mn |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | 164.82 Mn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | 21.90 Mn |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | -16.70 Mn |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | -2.26 Mn |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | 7.85 Mn |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | -3.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.90 Mn |
| Mar 31, 2026 | -25.00 Mn |
| Dec 31, 2025 | 45.90 Mn |
| Sep 30, 2025 | 50.10 Mn |
| Jun 30, 2025 | -24.70 Mn |
| Mar 31, 2025 | -19.70 Mn |
| Dec 31, 2024 | 19.50 Mn |
| Sep 30, 2024 | -24.50 Mn |
| Jun 30, 2024 | 35.10 Mn |
| Mar 31, 2024 | -13.50 Mn |
| Dec 31, 2023 | 1.70 Mn |
| Sep 30, 2023 | -3.10 Mn |
| Jun 30, 2023 | -9.10 Mn |
| Mar 31, 2023 | 6.30 Mn |
| Dec 31, 2022 | -800,000.00 |
| Sep 30, 2022 | 17.50 Mn |